What companies are EXEL's competitors?

Exelixis, Inc. (EXEL)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.

How does EXEL compare to its peers?

The peer comparison table on this page shows Exelixis, Inc. (EXEL) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.

What sector does EXEL operate in?

Exelixis, Inc. (EXEL) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

EXEL

Exelixis, Inc.

NASDAQ·Biotechnology · Healthcare

$54.98$1.14−2.03%

After hours·$54.98+0.00%

Market cap$13.82B·Market closed·Jul 22 8:00 PM UTC

Frequently Asked Questions About EXEL

What companies are EXEL's competitors?: Exelixis, Inc. (EXEL)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does EXEL compare to its peers?: The peer comparison table on this page shows Exelixis, Inc. (EXEL) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does EXEL operate in?: Exelixis, Inc. (EXEL) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

EXEL

Exelixis, Inc.

NASDAQ·Biotechnology · Healthcare

$54.98$1.14−2.03%

After hours·$54.98+0.00%

Market cap$13.82B·Market closed·Jul 22 8:00 PM UTC

Peers


RVMD	Revolution Medicines, Inc.	$182.96	$38.9B
MRNA	Moderna, Inc.	$58.07	$23.0B
BBIO	BridgeBio Pharma, Inc.	$82.66	$16.2B
MDGL	Madrigal Pharmaceuticals, Inc.	$537.65	$12.4B
ALGN	Align Technology, Inc.	$172.46	$12.4B
BMRN	BioMarin Pharmaceutical Inc.	$58.40	$11.3B
TECH	Bio-Techne Corporation	$71.78	$11.2B
HALO	Halozyme Therapeutics, Inc.	$77.82	$9.2B
CAI	Caris Life Sciences, Inc.	$15.38	$4.3B
RNA	Atrium Therapeutics, Inc.	$12.17	$208.2M

Frequently Asked Questions About EXEL

What companies are EXEL's competitors?: Exelixis, Inc. (EXEL)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does EXEL compare to its peers?: The peer comparison table on this page shows Exelixis, Inc. (EXEL) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does EXEL operate in?: Exelixis, Inc. (EXEL) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.